The Dutch Competition Authority conducts further investigations into whether the acquisition of a healthcare clinic could lead to higher prices for health insurers (Mauritskliniek / Bergman)

Further investigation needed into the acquisition of Mauritskliniek by Bergman Clinics* The Netherlands Authority for Consumers and Markets (ACM) has not yet cleared the acquisition of health care provider Mauritskliniek by rival provider Bergman Clinics. ACM wishes to conduct a further investigation into whether this acquisition could lead to higher prices for health insurers. That is why Bergman

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.